LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis
Apoptosis · 2026
DOI: 10.1007/s10495-026-02286-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2026. Verfasst von Qingling Jiang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Featured Laboratory for Biosynthesis and Target Discovery of Active Components of Traditional Chinese Medicine, School of Traditional Chinese Medicin…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Cell Differentiation, RNA, Long Noncoding, Cell Cycle Proteins. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Recently evidence has suggested that long non-coding RNAs (lncRNAs) play a pivotal role in the prognosis and treatment of leukemia. However, studies on their use in differentiation therapy of acute myeloid leukemia (AML) remain scarce. In this study, we found that AC098613.1 was significantly increased in differentiated THP-1 cells, while its expression was significantly lower in AML patients. Moreover, AC098613.1 overexpression inhibited proliferation and induced differentiation of THP-1 and HL-60 cells. Mechanistically, we found that AC098613.1 targeted cell division cycle 5-like protein (CDC5L) to increase its stability, thereby enhancing its abundance and nuclear localization, and promoted the transcription of ADP-ribosylation factor GTPase activating protein with dual PH domains 1 (ADAP1) and the expression of nardilysin (encoded by NRD1), which ultimately induced the differentiation of AML cells. We further demonstrated in vivo that AC098613.1 overexpression significantly inhibited tumor growth by affecting the stability of CDC5L and regulating the expression of ADAP1, NRD1 and cyclin-dependent kinase 1 (CDK1). The research demonstrates that AC098613.1 promotes AML cell differentiation by regulating the CDC5L/ADAP1/NRD1 axis, providing a new target for AML differentiation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Featured Laboratory for Biosynthesis and Target Discovery of Active Components of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Binzhou Medical University, Yantai, 264003, Shandong, China.
- Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264099, Shandong, China.
- Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, the "Double-First Class" Application Characteristic Discipline of Hunan Province (Pharmaceutical Science), Changsha M…
- Faculty of Health Sciences and Sports, Macao Polytechnic University, Macau, 999078, Macao, SAR, China.
- Department of Human Anatomy, College of Basic Medical Sciences, Binzhou Medical University, Yantai, 264003, Shandong, China. liuhongfu95@163.com.
- College of Traditional Chinese Medicine, Shandong Second Medical University, Weifang, 261053, Shandong, China. scgdoctor@126.com.
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Jiang, Q., Wang, X., Yao, H., Wang, J., Tang, P., Liang, M., Pan, Z., Li, B., Lin, C., Wu, Q., Wang, Q., Zheng, Q., Kuok, C. F., Liu, H., Sun, C., & Li, D. (2026). LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis. Apoptosis. https://doi.org/10.1007/s10495-026-02286-2
Vancouver
Jiang Q, Wang X, Yao H, Wang J, Tang P, Liang M, et al. LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis. Apoptosis. 2026. doi:10.1007/s10495-026-02286-2
BibTeX
@article{Jiang2026,
author = {Jiang, Qingling and Wang, Xiaoting and Yao, Hang and Wang, Jince and Tang, Peiyu and Liang, Mingpeng and Pan, Zhaohai and Li, Bohan and Lin, Chunhua and Wu, Qinxuan and Wang, Qi and Zheng, Qiusheng and Kuok, Chiu-Fai and Liu, Hongfu and Sun, Changgang and Li, Defang},
title = {LncRNA AC098613.1 promotes acute myeloid leukemia cell differentiation through CDC5L/ADAP1/NRD1 axis},
journal = {Apoptosis},
year = {2026},
doi = {10.1007/s10495-026-02286-2}
}
EUVIMED